Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
about
Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysisClarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication.Azithromycin in one week quadruple therapy for H pylori eradication in Iran.Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infectionReview article: alternative antibacterial agents for Helicobacter pylori eradication.A Comparison between Moderate- and High-dose Furazolidone in Triple Regimens for Helicobacterpylori Eradication in IranShort-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of Helicobacter pylori.Alternative and rescue treatment regimens for Helicobacter pylori eradication.Potential of fumarate reductase as a novel therapeutic target in Helicobacter pylori infection.Seven-day quintuple regimen as a rescue therapy for Helicobacter pylori eradicationAntibiotic susceptibility profile of Helicobacter pylori isolated from the dyspepsia patients in Tehran, IranReview article: the treatment of refractory Helicobacter pylori infection.Clarithromycin vs. Gemifloxacin in Quadruple Therapy Regimens for Empiric Primary Treatment of Helicobacter pylori Infection: A Randomized Clinical TrialHelicobacter pylori antibiotic resistance in Iran.Frequency of antibiotic resistance in Helicobacter pylori strains isolated from the northern population of Iran.Comparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori.Eradication of Helicobacter pylori: recent advances in treatment.Helicobacter pylori in Iran: A systematic review on the association of genotypes and gastroduodenal diseases.Effects of Clarithromycin-Containing Quadruple Therapy on Helicobacter Pylori Eradication after Nitroimidazole-Containing Quadruple Therapy FailureNitrofuran-based regimens for the eradication of Helicobacter pylori infection.Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori.Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer diseaseThe effect of helicobacter pylori eradication on liver fat content in subjects with non-alcoholic Fatty liver disease: a randomized open-label clinical trial.Helicobacter pylori eradication in West Asia: a reviewRole of bismuth in improving Helicobacter pylori eradication with triple therapy.Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran.Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies.Tetracycline- and furazolidone-containing quadruple regimen as rescue treatment for Helicobacter pylori infection: a single center retrospective study.Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the pediatric medical center of Tehran, IranEffect of different doses of furazolidone with amoxicillin and omeprazole on eradication of Helicobacter pylori.Does delayed gastric emptying shorten the H pylori eradication period? A double blind clinical trial.Third-line rescue therapy for Helicobacter pylori infection.One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies.Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures.Omeprazole, furazolidone, and tetracycline: an eradication treatment for resistant H. pylori in Brazilian patients with peptic ulcer disease.Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population.Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication.High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection.Helicobacter pylori reinfection rate 3 years after successful eradication.Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone.
P2860
Q26823010-96E1A031-1C8E-420C-8E9C-F7AB7BAAFC36Q33798957-E4C0AFC6-DC26-42CF-8A63-1928559B4F8DQ34017671-5F03522C-DD8A-4194-9EFF-EB50955417BAQ34093938-CDC9CA73-5D43-48E8-8CE8-23FB6B8DB05AQ34374147-60D891C7-CB7D-4E0E-ABF5-6909B9402D6CQ34401441-B1FAA25C-F643-432A-A111-4A994A7B650DQ34501295-264CE46A-7458-4DB2-BB8D-ABEC99900895Q34789141-8DE8A1B7-A7D1-4BD2-93DC-4ADA7D9B90AFQ34837506-AC468D3C-41BC-4B93-ABF5-B0AE40CD2FB3Q34932701-063EF0D5-D067-4246-B54A-B40FC81E1661Q35098365-C64A0F9C-BF8E-412C-ABC7-267D4AE6C6E4Q35145092-1A4CCC39-B206-4417-B3F8-8A7C8BDB1FD4Q35603893-648B6F0E-91CC-4C11-9944-4386FB3CD2F0Q35621623-CDE29F0F-B7F9-4817-85FE-2F1ADBF3A6F1Q35744435-141BAC76-3462-4E51-8BA2-BB6B54CB63D7Q35765342-5A92D160-DD5C-4FA9-8B66-AA6439127100Q36191284-3C36F9EF-4C44-4CFB-9022-6FE5BA64D04CQ36479958-81EF966A-407D-4610-8B14-915520366901Q36636379-47B81F8F-1B32-4403-BF0F-92DD7B83B207Q36936445-409FA6D7-CAF1-4209-ACA6-878F6B03A023Q37122418-B9D71627-6AE7-4127-91E7-9357EC9E4BD4Q37386612-E217875F-91EE-447E-8742-CAE9D263B47CQ37401092-A051F0CB-7169-4616-AC64-B86D0694051EQ38240846-F74E33C2-33FC-4B83-A3B7-73F0CA9A60B3Q38723877-E8501467-7397-4349-A028-C107AF2A5A37Q38747268-8E8DC877-8B47-4104-8E3B-3DC22E4E7EDBQ39278632-8C24314E-FF8D-402F-83F5-B9061CCA4740Q40206483-F4C6D505-4C73-4ABA-9165-75361D5B38B2Q40470285-ABF50EBC-6A71-4939-B495-47C4263FFD9CQ40557289-551D7BAE-7B28-4C22-826C-346E332F0C7FQ42267363-F76CA1E9-1891-4388-8258-498E4E4C7CA6Q42726333-E14C2265-3C81-43A2-937D-F6879946ED68Q43944820-29906238-D91A-4D75-8867-36B3CCC95EFEQ44091802-4EFC2336-F180-4B54-9F81-C9D18977FEE1Q44219479-C14AEAC5-CB1A-45BD-8F4C-AA978C717A92Q44272852-AF10CF05-B586-4603-8103-350ED0A386ACQ44700482-D2F4E97E-ADBF-4552-B9D4-5886A1329343Q44813868-6E5DDD5C-F7CA-429C-ACE2-1431AF6897C2Q45289732-2C51CFD0-0EDA-49D4-93DB-909077FF5FCEQ46753199-C8134492-7B3D-4625-A546-A8138BB0ED99
P2860
Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clarithromycin vs. furazolidon ...... metronidazole resistance rate.
@ast
Clarithromycin vs. furazolidon ...... metronidazole resistance rate.
@en
type
label
Clarithromycin vs. furazolidon ...... metronidazole resistance rate.
@ast
Clarithromycin vs. furazolidon ...... metronidazole resistance rate.
@en
prefLabel
Clarithromycin vs. furazolidon ...... metronidazole resistance rate.
@ast
Clarithromycin vs. furazolidon ...... metronidazole resistance rate.
@en
P2093
P2860
P1476
Clarithromycin vs. furazolidon ...... metronidazole resistance rate.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2001.00931.X
P407
P577
2001-03-01T00:00:00Z